Company registration number 05723493 (England and Wales)
KPI (NOMINEES) LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
KPI (NOMINEES) LIMITED
COMPANY INFORMATION
Directors
J F Massing
G S Wilder
Secretary
J F Massing
Company number
05723493
Registered office
3 Coldbath Square
London
EC1R 5HL
Auditor
Stephen Iseman & Co
Registered Auditors
Chartered Accountants
30 Oakridge Avenue
Radlett
Herts
WD7 8ER
KPI (NOMINEES) LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 7
KPI (NOMINEES) LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Non-current assets
Investments
4
9,427,714
9,180,073
Current assets
Trade and other receivables
7
10,225,386
2,834,517
Investments
8
2,232,907
28,109,162
Cash and cash equivalents
15,907,999
7,213,227
28,366,292
38,156,906
Current liabilities
9
(714,690)
(1,109,840)
Net current assets
27,651,602
37,047,066
Net assets
37,079,316
46,227,139
Equity
Called up share capital
10
1
1
Retained earnings
11
37,079,315
46,227,138
Total equity
37,079,316
46,227,139

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 9 December 2025 and are signed on its behalf by:
J F Massing
G S Wilder
Director
Director
Company registration number 05723493 (England and Wales)
KPI (NOMINEES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

KPI (Nominees) Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3 Coldbath Square, London, EC1R 5HL.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest pound.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.

1.2
Revenue

Revenue represents the fair value of the consideration for management fees receivable net of VAT. All income is recognised in the period to which it relates.

1.3
Non-current investments

Interests in subsidiaries and other unlisted entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in the Statement of Comprehensive Income.

1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

KPI (NOMINEES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -

Trade and other receivables

Trade and other receivables, including loans, are initially measured at transaction price and are subsequently carried at amortised cost using the effective interest method less impairment losses for bad and doubtful debts.

 

Current asset Investments

All current asset investments are initially measured at cost. Subsequently, listed investments are restated at fair value at the reporting end date with any gains or losses recognised in the Statement of Comprehensive Income. Other investments are measured at cost less any accumulated impairment losses. These other investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in the Statement of Comprehensive Income.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting end date. The impairment loss is recognised in the Statement of Comprehensive Income.

Trade and other payables

Trade and other payables are initially recognised at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on the taxable profit for the year. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.8
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation are included in the Statement of Comprehensive Income for the period.

2
Auditor's remuneration
2025
2024
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
6,500
6,500
KPI (NOMINEES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
4
Fixed asset investments
2025
2024
£
£
Investments
621,145
235,889
Loans
8,806,569
8,944,184
9,427,714
9,180,073
Movements in non-current investments
Shares in group undertakings and participating interests
Loans to group undertakings
Other loans
Total
£
£
£
£
Cost
At 1 April 2024
235,889
6,255,118
2,689,066
9,180,073
Additions
385,256
1,060,657
171,817
1,617,730
Repaid
-
(656,478)
(713,611)
(1,370,089)
At 31 March 2025
621,145
6,659,297
2,147,272
9,427,714
Carrying amount
At 31 March 2025
621,145
6,659,297
2,147,272
9,427,714
At 31 March 2024
235,889
6,255,118
2,689,066
9,180,073
KPI (NOMINEES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
5
Subsidiaries

Details of the company's subsidiaries at 31 March 2025 are as follows:

Name of undertaking
Address
Class of
% Held
shares held
Direct
Indirect
29-31 Eastways Limited
1
Ordinary
100.00
-
Gentleaid (13) Limited
1
Ordinary
100.00
-
Gentleaid (16) Limited
1
Ordinary
100.00
-
Gentleaid (17) Limited
1
Ordinary
100.00
-
Porterfield Financial Holdings Limited
2
Ordinary
100.00
-
Fresh Start UK Debt Management Limited
2
Ordinary
-
100.00
Durham Filtration Limited
1
Ordinary
-
100.00
Gentleaid (23) Limited
1
Ordinary
100.00
-
Gentleaid (24) Limited
1
Ordinary
100.00
-
2-20 Booth Drive Limited
1
Ordinary
100.00
-

Registered office addresses (all UK unless otherwise indicated):

1
3 Coldbath Square, London, EC1R 5HL, England
2
Fourth Floor, 48-50 Lowgate, Hull, England, HU1 1EN
6
Associates

Details of the company's associates at 31 March 2025 are as follows:

Name of undertaking
Registered
Nature of business
Class of
% Held
office key
shares held
Direct
Indirect
Moor Park Capital Partners
LLP
1
Real estate investment
management and advisory
services
Ordinary interest
50.00
0
MP Hospital Investments
Limited
2
Investment holding
Ordinary
50.00
0
MPLA Owners Limited
2
Advisory services
Ordinary
50.00
0
MP Links Advisers Limited
2
Advisory services
Ordinary
-
50.00
Bragg Street LLC
3
Investment holding
Ordinary interest
-
50.00
Speedpac Limited
4
Packaging activities
Ordinary
-
20.00
Kingswood (CBS) Limited
4
Property investment
Ordinary
20.00
0

Registered Office addresses:

 

1     C/O Add Value Accountancy, 49 Church Road, Hove, England, BN3 2BE

 

2     22 Grenville Street, St Helier, Jersey JE4 8PX

 

3 c/o Tarter Krinsky & Drogin LLP , 1350 Broadway, New York, NY 10018, USA

 

4     3 Coldbath Square, London, EC1R 5HL, England

 

KPI (NOMINEES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
7
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Trade receivables
-
0
60,000
Corporation tax recoverable
320,996
-
0
Amounts owed by group undertakings
2,500,592
500,203
Amounts owed by undertakings in which the company has a participating interest
371,221
270,388
Other receivables
7,032,577
2,003,926
10,225,386
2,834,517

Trade receivables disclosed above are measured at amortised cost.

8
Current asset investments
2025
2024
£
£
Listed investments at fair value
2,232,907
23,129,723
Other investments at cost
-
0
4,979,439
2,232,907
28,109,162
9
Current liabilities
2025
2024
£
£
Trade payables
270,060
39,600
Amounts owed to group undertakings
90,000
90,000
Corporation tax
-
0
456,397
Other taxation and social security
4,860
9,767
Other payables
105,025
362,502
Accruals and deferred income
244,745
151,574
714,690
1,109,840
10
Called up share capital
2025
2024
£
£
Ordinary share capital
Issued and fully paid
1 Ordinary share of £1
1
1
11
Retained earnings

As at 31 March 2025, the retained earnings reserve included £nil (2024: £2,818,803) which is not distributable.

KPI (NOMINEES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
12
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

Opinion

In our opinion the financial statements:

Senior Statutory Auditor:
Stephen Iseman FCA
Statutory Auditor:
Stephen Iseman & Co
Date of audit report:
9 December 2025
13
Related party transactions

During the year, the company has charged management fees of £535,000 (2024: £262,500) to Moor Park Capital LLP, an entity registered in England in which the company has a material interest.

 

The company has taken advantage of the exemption available under FRS 102 chapter 33 not to disclose transactions or balances with its parent company and wholly owned subsidiaries.

14
Controlling party

The company is 100% controlled by its immediate and ultimate parent undertaking, Kingswood Property Finance Limited Partnership, a limited partnership incorporated in England with its registered office at 3 Coldbath Square, London, EC1R 5HL.

2025-03-312024-04-01falsefalsefalse09 December 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityG S WilderG S WilderJ F Massing057234932024-04-012025-03-3105723493bus:CompanySecretaryDirector12024-04-012025-03-3105723493bus:Director12024-04-012025-03-3105723493bus:CompanySecretary12024-04-012025-03-3105723493bus:Director22024-04-012025-03-3105723493bus:RegisteredOffice2024-04-012025-03-31057234932025-03-31057234932024-03-3105723493core:ShareCapital2025-03-3105723493core:ShareCapital2024-03-3105723493core:RetainedEarningsAccumulatedLosses2025-03-3105723493core:RetainedEarningsAccumulatedLosses2024-03-3105723493core:ShareCapitalOrdinaryShareClass12025-03-3105723493core:ShareCapitalOrdinaryShareClass12024-03-31057234932023-04-012024-03-3105723493core:Non-currentFinancialInstruments2025-03-3105723493core:Non-currentFinancialInstruments2024-03-3105723493core:CurrentFinancialInstrumentscore:ListedExchangeTraded2025-03-3105723493core:CurrentFinancialInstrumentscore:ListedExchangeTraded2024-03-3105723493core:CurrentFinancialInstrumentscore:UnlistedNon-exchangeTraded2025-03-3105723493core:CurrentFinancialInstrumentscore:UnlistedNon-exchangeTraded2024-03-3105723493core:CurrentFinancialInstruments2025-03-3105723493core:CurrentFinancialInstruments2024-03-3105723493core:Subsidiary12024-04-012025-03-3105723493core:Subsidiary22024-04-012025-03-3105723493core:Subsidiary32024-04-012025-03-3105723493core:Subsidiary42024-04-012025-03-3105723493core:Subsidiary52024-04-012025-03-3105723493core:Subsidiary62024-04-012025-03-3105723493core:Subsidiary72024-04-012025-03-3105723493core:Subsidiary82024-04-012025-03-3105723493core:Subsidiary92024-04-012025-03-3105723493core:Subsidiary102024-04-012025-03-3105723493core:Subsidiary112024-04-012025-03-3105723493core:Subsidiary222024-04-012025-03-3105723493core:Subsidiary332024-04-012025-03-3105723493core:Subsidiary442024-04-012025-03-3105723493core:Subsidiary552024-04-012025-03-3105723493core:Subsidiary662024-04-012025-03-3105723493core:Subsidiary772024-04-012025-03-3105723493core:Subsidiary882024-04-012025-03-3105723493core:Subsidiary992024-04-012025-03-3105723493core:Subsidiary10102024-04-012025-03-310572349362024-04-012025-03-310572349372024-04-012025-03-3105723493core:Associate12024-04-012025-03-3105723493core:Associate22024-04-012025-03-3105723493core:Associate32024-04-012025-03-3105723493core:Associate42024-04-012025-03-3105723493core:Associate52024-04-012025-03-3105723493core:Associate62024-04-012025-03-3105723493core:Associate72024-04-012025-03-3105723493core:Associate112024-04-012025-03-3105723493core:Associate222024-04-012025-03-3105723493core:Associate332024-04-012025-03-3105723493core:Associate442024-04-012025-03-3105723493core:Associate552024-04-012025-03-3105723493core:Associate662024-04-012025-03-3105723493core:Associate772024-04-012025-03-310572349342024-04-012025-03-310572349352024-04-012025-03-310572349362024-04-012025-03-3105723493bus:PrivateLimitedCompanyLtd2024-04-012025-03-3105723493bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3105723493bus:FRS1022024-04-012025-03-3105723493bus:Audited2024-04-012025-03-3105723493bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP